Literature DB >> 21118132

Translation deregulation in B-cell lymphomas.

Emilie Horvilleur1, Lindsay A Wilson, Anne E Willis.   

Abstract

B-cell lymphomas are a heterogeneous group of diseases that can arise at different stages of B-cell development, often as a result of errors in the cells' unique ontogeny. Common oncogenic features are often observed, including chromosomal rearrangements, somatic mutations and transcriptional change. Disruption of translation regulation is also frequently implicated in both B-cell lymphoma development and progression. Deregulation of translation in lymphomagenesis can arise through changes to the proteins constituting the translational machinery or to their regulators, and to changes in miRNA (microRNA) expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118132     DOI: 10.1042/BST0381593

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  2 in total

1.  MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2.

Authors:  Xi Xie; Yu-Sheng Li; Wen-Feng Xiao; Zhen-Han Deng; Hong-Bo He; Qing Liu; Wei Luo
Journal:  Biosci Rep       Date:  2017-05-17       Impact factor: 3.840

2.  Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development.

Authors:  Krystyna Mazan-Mamczarz; X Frank Zhao; Bojie Dai; James J Steinhardt; Raymond J Peroutka; Kimberly L Berk; Ari L Landon; Mariola Sadowska; Yongqing Zhang; Elin Lehrmann; Kevin G Becker; Rita Shaknovich; Zhenqiu Liu; Ronald B Gartenhaus
Journal:  PLoS Genet       Date:  2014-01-30       Impact factor: 5.917

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.